Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Jiangsu Jiaerke Pharmaceuticals Group

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-07-26

    Jiangsu Jiaerke Pharmaceuticals Group

    City : Changzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-07-26

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-12

    Jiangsu Jiaerke Pharmaceuticals Group

    City : Changzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-04-28

    Jiangsu Jiaerke Pharmaceuticals Group

    City : Changzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-04-28

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-09-17

    Jiangsu Jiaerke Pharmaceuticals Group

    City : Changzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2009-09-17

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Jiangsu Jiaerke Pharmaceuticals Group and get a quotation

    Jiangsu Jiaerke Pharmaceuticals Group is a supplier offers 13 products (APIs, Excipients or Intermediates).

    Find Progesterone bulk with CEP, JDMF offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Prasterone bulk with DMF offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Prasterone Acetate bulk with DMF offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Progesterone bulk with DMF offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Testosterone bulk with CEP offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Benzocaine bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Dehydroepiandrosterone bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Prasterone bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Pregnenolone bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Testosterone bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Testosterone Cypionate bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Testosterone Enanthate bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    Find Testosterone Propionate bulk offered by Jiangsu Jiaerke Pharmaceuticals Group

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.